Jinquan Luo
50Patents
9h-index
122Co-inventors
77Inventor score
Filing activity: Dec 20, 2005 → Mar 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7491391B2 | Anti-IL-23 antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 60 | Active |
| US7807414B2 | Anti-IL-23 antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 29 | Active |
| US9090694B2 | ST2L antibody antagonists | Chemistry; Metallurgy | 18 | Active |
| US9212227B2 | ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions | Chemistry; Metallurgy | 12 | Active |
| US9850310B2 | CD123 binding agents and uses thereof | Chemistry; Metallurgy | 12 | Active |
| US9522957B2 | Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists | Chemistry; Metallurgy | 10 | Active |
| US9790281B2 | Humanized anti-CD134 (OX40) antibodies and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US9255153B2 | Polynucleotides encoding Toll-Like Receptor 3 antagonists | Chemistry; Metallurgy | 10 | Active |
| US8519107B2 | IL-17A antibodies | Chemistry; Metallurgy | 10 | Active |
| US9481731B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 9 | Active |
| US9428579B2 | Method of treating Crohn's disease by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 8 | Active |
| US8080247B2 | Anti-IL-12 antibodies | Chemistry; Metallurgy | 5 | Active |
| US10844122B2 | Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US8329170B2 | Method for treating psoriasis by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 4 | Active |
| US9238693B2 | Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies | Chemistry; Metallurgy | 3 | Active |
| US10273307B2 | Humanized anti-CD134 (OX40) antibodies and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8409567B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 2 | Active |
| US8460659B2 | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases | Chemistry; Metallurgy | 2 | Active |
| US9862766B2 | Method of treating lupus by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 2 | Active |
| US11746161B2 | Antibodies that specifically bind PD-1 and methods of use | Chemistry; Metallurgy | 2 | Active |
| US10208113B2 | Interferon α and ω antibody antagonists | Emerging Cross-Sectional Technologies | 2 | Active |
| US10781246B2 | Compositions and methods for anti-staphylococcal biologic agents | Physics | 2 | Active |
| US9951137B2 | ST2L antagonists and methods of use | Chemistry; Metallurgy | 2 | Active |
| US8540986B2 | Toll-like receptor 3 antagonists | Chemistry; Metallurgy | 2 | Active |
| US11236155B2 | Antibodies to pyroglutamate amyloid-β and uses thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.